FindTrial
Sign In

Ex-vivo/in vitro studies on immune-activators and blockers in hidradenitis suppurativa

Ex-vivo/in vitro studies on immune-activators and blockers in hidradenitis suppurativa - Immune activation in hidradenitis suppurativa

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50846
Enrollment
30
Registered
2021-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

De proefpersonen fungeren als de controle groep van patienten met de huidziekte hidradenitis suppurativa. acne inversa verneuil's disease

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria cases - hidradenitis suppurativa patients - Participating in HiScreen Biobank - Informed consent available for bloodsamples Inclusion healthy volunteers - Adult (>18 years old) not suffering from HS - Competent and willing to provide informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria for hidradentis suppurativa patients -

Design outcomes

Primary

MeasureTime frame
The main study parameter is the difference of immune response to above mentioned hidradenitis suppurativa triggering factors, forexample the cytokine/antimicrobial profile after microbial exposure in HS patients compared to healthy controls.—

Secondary

MeasureTime frame
N.A.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)